Drugs / ONO-5129
last change Oct 2007 re-read 3 minutes ago

ONO-5129

Developed for
type 2 diabetes mellitus
Investigated by
Ono Pharma USA Inc

Trials 2

20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00335712 Jun 2006 → ? type 2 diabetes mellitus Ono Pharma USA Inc Completed No outcome recorded
Phase 2 NCT00212641 Jun 2005 → Oct 2007 type 2 diabetes mellitus Ono Pharma USA Inc Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as ONO-5129 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00335712 ↗
1

NCT00212641 ↗